$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000162828018003541 Filed on March 26, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$182.6M	$198.7M	$218.1M
YoY Change	-23.96%	-11.51%	-6.18%
Cost Of Revenue	$112.4M	$132.1M	$150.5M
YoY Change	-33.49%	-18.42%	-10.58%
Gross Profit	$70.19M	$66.56M	$67.61M
YoY Change	-4.88%	7.84%	6.87%
Gross Profit Margin	38.45%	33.5%	31.0%
Selling, General & Admin	$15.30M	$15.90M	$15.80M
YoY Change	-0.65%	-10.17%	15.33%
% of Gross Profit	21.8%	23.89%	23.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.400M	$7.100M	$7.000M
YoY Change	-28.89%	69.05%	62.79%
% of Gross Profit	9.12%	10.67%	10.35%
Operating Expenses	$62.70M	$62.30M	$65.10M
YoY Change	3.12%	-3.41%	11.09%
Operating Profit	$7.494M	$4.263M	$2.511M
YoY Change	-42.32%	-253.4%	-46.19%
Interest Expense	-$13.40M	-$13.40M	-$12.60M
YoY Change	42.55%	44.09%	32.63%
% of Operating Profit	-178.81%	-314.33%	-501.79%
Other Income/Expense, Net
YoY Change
Pretax Income	-$7.202M	-$13.00M	-$28.43M
YoY Change	77.21%	18.03%	224.2%
Income Tax	-$73.20M	$60.00K	$718.0K
% Of Pretax Income
Net Earnings	-$1.962M	-$12.99M	-$29.52M
YoY Change	-84.74%	14.7%	237.41%
Net Earnings / Revenue	-1.07%	-6.54%	-13.54%
Basic Earnings Per Share
Diluted Earnings Per Share	-$62.70K	-$407.5K	-$973.6K
COMMON SHARES
Basic Shares Outstanding	127.5M shares	127.5M shares	121.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.50M	$33.00M	$40.50M
YoY Change	311.46%	1078.57%	-21.21%
Cash & Equivalents	$39.46M	$33.01M	$40.53M
Short-Term Investments
Other Short-Term Assets	$23.60M	$20.20M	$18.10M
YoY Change	27.57%	3.59%	9.7%
Inventory	$38.04M	$27.78M	$28.82M
Prepaid Expenses
Receivables	$85.52M	$89.20M	$103.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$186.6M	$170.2M	$190.5M
YoY Change	7.65%	6.78%	-4.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.97M	$28.73M	$30.06M
YoY Change	-17.46%	-14.78%	-2.36%
Goodwill	$627.4M	$367.2M	$365.9M
YoY Change	71.44%	-1.57%	18.53%
Intangibles	$19.11M
YoY Change	-38.43%
Long-Term Investments
YoY Change
Other Assets	$2.116M	$2.415M	$2.204M
YoY Change	6.33%	17.52%	83.21%
Total Long-Term Assets	$416.5M	$420.1M	$422.9M
YoY Change	-3.51%	-3.66%	22.85%
TOTAL ASSETS
Total Short-Term Assets	$186.6M	$170.2M	$190.5M
Total Long-Term Assets	$416.5M	$420.1M	$422.9M
Total Assets	$603.1M	$590.2M	$613.4M
YoY Change	-0.31%	-0.87%	12.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.96M	$42.69M	$46.38M
YoY Change	2.4%	-6.58%	-5.13%
Accrued Expenses	$32.80M	$39.60M	$49.90M
YoY Change	-24.6%	-8.12%	25.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.722M	$1.800M	$1.700M
YoY Change	-90.7%	-96.27%	-81.91%
Total Short-Term Liabilities	$105.1M	$89.03M	$102.9M
YoY Change	-19.22%	-36.82%	1.2%
LONG-TERM LIABILITIES
Long-Term Debt	$478.9M	$476.8M	$475.7M
YoY Change	10.5%	22.85%	21.94%
Other Long-Term Liabilities	$21.77M	$18.88M	$17.94M
YoY Change	2753.08%	319.35%	984.11%
Total Long-Term Liabilities	$21.77M	$18.88M	$17.94M
YoY Change	2753.08%	319.35%	984.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$105.1M	$89.03M	$102.9M
Total Long-Term Liabilities	$21.77M	$18.88M	$17.94M
Total Liabilities	$605.8M	$588.8M	$600.0M
YoY Change	6.91%	7.05%	21.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$709.5M	-$704.6M	-$692.0M
YoY Change	9.95%	11.67%	11.68%
Common Stock	$624.8M	$626.6M	$628.6M
YoY Change	2.14%	3.28%	2.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$16.00K	$16.00K
YoY Change
Treasury Stock Shares	5.106K shares	5.106K shares
Shareholders Equity	$606.1M	-$78.00M	-$63.49M
YoY Change
Total Liabilities & Shareholders Equity	$603.1M	$590.2M	$613.4M
YoY Change	-0.31%	-0.87%	12.91%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	-$1.962M	-$12.99M	-$29.52M
YoY Change	-84.74%	14.7%	237.41%
Depreciation, Depletion And Amortization	$6.400M	$7.100M	$7.000M
YoY Change	-28.89%	69.05%	62.79%
Cash From Operating Activities	$8.600M	-$4.400M	$6.000M
YoY Change	-315.0%	-73.96%	-156.6%
INVESTING ACTIVITIES
Capital Expenditures	-$2.100M	-$2.300M	-$2.600M
YoY Change	10.53%	-8.0%	-16.13%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$2.100M	-$2.300M	-$2.600M
YoY Change	16.67%	-96.57%	-13.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	-900.0K	21.10M
YoY Change	-100.8%	-102.54%	-62.98%
NET CHANGE
Cash From Operating Activities	8.600M	-4.400M	6.000M
Cash From Investing Activities	-2.100M	-2.300M	-2.600M
Cash From Financing Activities	-100.0K	-900.0K	21.10M
Net Change In Cash	6.400M	-7.600M	24.50M
YoY Change	-4.48%	-84.36%	-43.55%
FREE CASH FLOW
Cash From Operating Activities	$8.600M	-$4.400M	$6.000M
Capital Expenditures	-$2.100M	-$2.300M	-$2.600M
Free Cash Flow	$10.70M	-$2.100M	$8.600M
YoY Change	-609.52%	-85.42%	-214.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	36822000	USD
CY2017Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	26118000	USD
CY2015	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	24405000	USD
CY2016	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	15859000	USD
CY2017	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	12662000	USD
CY2016	bios	Adjustments To Additional Paid In Capital Value Of Equity Linked Liabilities To Be Reclassified To Equity AdjustmentsToAdditionalPaidInCapitalValueOfEquityLinkedLiabilitiesToBeReclassifiedToEquity	2847000	USD
CY2015	bios	Adjustmentsto Additional Paidin Capital Accretionof Discounton Temporary Equity AdjustmentstoAdditionalPaidinCapitalAccretionofDiscountonTemporaryEquity	3690000	USD
CY2016	bios	Adjustmentsto Additional Paidin Capital Accretionof Discounton Temporary Equity AdjustmentstoAdditionalPaidinCapitalAccretionofDiscountonTemporaryEquity	692000	USD
CY2017	bios	Adjustmentsto Additional Paidin Capital Accretionof Discounton Temporary Equity AdjustmentstoAdditionalPaidinCapitalAccretionofDiscountonTemporaryEquity	701000	USD
CY2015	bios	Adjustmentsto Additional Paidin Capital Increasein Liquidation Preferenceon Temporary Equity AdjustmentstoAdditionalPaidinCapitalIncreaseinLiquidationPreferenceonTemporaryEquity	6120000	USD
CY2016	bios	Adjustmentsto Additional Paidin Capital Increasein Liquidation Preferenceon Temporary Equity AdjustmentstoAdditionalPaidinCapitalIncreaseinLiquidationPreferenceonTemporaryEquity	8392000	USD
CY2017	bios	Adjustmentsto Additional Paidin Capital Increasein Liquidation Preferenceon Temporary Equity AdjustmentstoAdditionalPaidinCapitalIncreaseinLiquidationPreferenceonTemporaryEquity	9376000	USD
CY2016Q4	bios	Allowancefor Doubtful Accounts Percentageof Accounts Receivable AllowanceforDoubtfulAccountsPercentageofAccountsReceivable	0.291
CY2017Q4	bios	Allowancefor Doubtful Accounts Percentageof Accounts Receivable AllowanceforDoubtfulAccountsPercentageofAccountsReceivable	0.307
CY2016Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3679000	USD
CY2017Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	4621000	USD
CY2017Q4	bios	Business Combination Contingent Consideration Arrangements Payment BusinessCombinationContingentConsiderationArrangementsPayment	500000	USD
CY2017Q4	bios	Business Combination Contingent Consideration Shortfall In Government Receivables BusinessCombinationContingentConsiderationShortfallInGovernmentReceivables	400000	USD
CY2015	bios	Change In Fair Value Of Equity Linked Liabilities ChangeInFairValueOfEquityLinkedLiabilities	0	USD
CY2016	bios	Change In Fair Value Of Equity Linked Liabilities ChangeInFairValueOfEquityLinkedLiabilities	10450000	USD
CY2017	bios	Change In Fair Value Of Equity Linked Liabilities ChangeInFairValueOfEquityLinkedLiabilities	-3587000	USD
CY2015	bios	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount	0	USD
CY2016	bios	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount	0	USD
CY2017	bios	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount	-925000	USD
CY2017Q4	bios	Future Minimum Leases Due Thereafter FutureMinimumLeasesDueThereafter	4891000	USD
CY2017Q4	bios	Future Minimum Payments Due FutureMinimumPaymentsDue	28579000	USD
CY2017Q4	bios	Future Minimum Payments Due Current FutureMinimumPaymentsDueCurrent	9461000	USD
CY2017Q4	bios	Future Minimum Payments Due In Five Years FutureMinimumPaymentsDueInFiveYears	1829000	USD
CY2017Q4	bios	Future Minimum Payments Due In Four Years FutureMinimumPaymentsDueInFourYears	2559000	USD
CY2017Q4	bios	Future Minimum Payments Due In Three Years FutureMinimumPaymentsDueInThreeYears	4075000	USD
CY2017Q4	bios	Future Minimum Payments Due In Two Years FutureMinimumPaymentsDueInTwoYears	5764000	USD
CY2015	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	0	USD
CY2016	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	3954000	USD
CY2017	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	-581000	USD
CY2015	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	-1377000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	65963000	USD
CY2016Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	153816000	USD
CY2016	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	308000	USD
CY2017	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	942000	USD
CY2015	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	30000	USD
CY2016	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	4597000	USD
CY2017	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	0	USD
CY2017Q4	bios	Number Of Stock Based Compensation Plans NumberOfStockBasedCompensationPlans	1	stock_compensation_plan
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	64420000	USD
CY2017	bios	Number Of Types Of Accounts Receivable NumberOfTypesOfAccountsReceivable	3	accounts_receivable
CY2015	bios	Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	-108000	USD
CY2016	bios	Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	-202000	USD
CY2017	bios	Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	120000	USD
CY2016Q2	bios	Saleof Stock Equity Issuable Amount SaleofStockEquityIssuableAmount	200000000.0	USD
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127697318	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	346641944	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	123434000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	75686000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	88298000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	611682000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	624762000	USD
CY2015	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	58000	USD
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	33000	USD
CY2017	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	16000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	187691000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	300000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6998000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5100000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6200000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11800000	USD
CY2016Q4	us-gaap	Assets Assets	604985000	USD
CY2017Q4	us-gaap	Assets Assets	603092000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	173327000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5309000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3725000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2360000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	44730000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37912000	USD
CY2017	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-3000000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3440000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4042000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	100000	USD
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	2314000	USD
CY2017	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1825000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	2863000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	1722000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	387000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	754000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	740000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15577000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9569000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39457000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14837000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6008000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	29888000	USD
CY2015	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	24565000	USD
CY2016	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2017	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2015	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1483000	USD
CY2016	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-7019000	USD
CY2017	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-6393000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117682543	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127634012	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117682543	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127634012	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	722271000	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	673507000	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	547948000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-925000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-76000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-30000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-751000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-76000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-30000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	174000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2600000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-18293000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1744000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1951000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	12452000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3656000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21456000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2045000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3379000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3163000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	301000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1428000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	25268000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	12757000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	177507000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	139516000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross Noncurrent DeferredTaxAssetsGrossNoncurrent	1098000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1098000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	1098000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	122420000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	110773000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	638000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2578000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2813000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6887000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2371000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	467000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	95000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	19249000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	10707000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	179788000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	138238000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2281000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	2281000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	180000	USD
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1300000	USD
CY2017	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2015	us-gaap	Depreciation Depreciation	22864000	USD
CY2016	us-gaap	Depreciation Depreciation	22025000	USD
CY2017	us-gaap	Depreciation Depreciation	27725000	USD
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.51
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.55
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2017Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1600000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28207000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	40436000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	0	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8644000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	0	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	0	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4252000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6218000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	59250000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	59550000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31043000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	19114000	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3954000	USD
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-581000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13453000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42474000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38798000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	39625000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	308729000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	365947000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	367198000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	57218000	USD
CY2015Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	251900000	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	251850000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	1251000	USD
CY2015	us-gaap	Gross Profit GrossProfit	259952000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	63302000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	63266000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	61721000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	73793000	USD
CY2016	us-gaap	Gross Profit GrossProfit	262082000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	64874000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	67611000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	66563000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	70194000	USD
CY2017	us-gaap	Gross Profit GrossProfit	269242000	USD
CY2015	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	982223000	USD
CY2016Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	238462000	USD
CY2016Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	232462000	USD
CY2016Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	224542000	USD
CY2016Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	240123000	USD
CY2016	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	935589000	USD
CY2017Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	217810000	USD
CY2017Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	218106000	USD
CY2017Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	198692000	USD
CY2017Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	182582000	USD
CY2017	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	817190000	USD
CY2015Q1	us-gaap	Impact Of Restatement On Opening Retained Earnings Net Of Tax ImpactOfRestatementOnOpeningRetainedEarningsNetOfTax	400000	USD
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-304819000	USD
CY2016	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-36172000	USD
CY2017	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-63303000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-326351000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10311000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8770000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11012000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4064000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-34157000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18801000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-28432000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12998000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7202000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-67433000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-4.58
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.17
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.14
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.11
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.06
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.48
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.18
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.26
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.12
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.03
CY2017	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.59
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4691000	USD
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	504000	USD
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	169000	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	107000	USD
CY2016Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-7373000	USD
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-6593000	USD
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-299000	USD
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-373000	USD
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	66000	USD
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-287000	USD
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-893000	USD
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.07
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2016Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.07
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.07
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.01
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.01
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-21532000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2015000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4130000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	57567000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14725000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-41550000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	67707000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-114222000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11907000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23654000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	43362000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	212000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	661000	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1111000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-8414000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1398000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-4587000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-37000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-66000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-10000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	114000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-372000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	649000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-23381000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-15977000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	689000	USD
CY2015	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	20089000	USD
CY2016	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2045000	USD
CY2017	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	3379000	USD
CY2015	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	45000	USD
CY2016	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-192000	USD
CY2017	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5769000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10016000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2544000	USD
CY2015	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8020000	USD
CY2016	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1305000	USD
CY2017	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-4805000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	734000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	893000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	239000	USD
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-18760000	USD
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2219000	USD
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-23564000	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2017	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	4950000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	31043000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19114000	USD
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-36938000	USD
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-37572000	USD
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-52072000	USD
CY2015	us-gaap	Interest Paid Net InterestPaidNet	34302000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	34696000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	45376000	USD
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6705000	USD
CY2017Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6706000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	36165000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	38044000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7200000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7300000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7700000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	566604000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	605765000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	604985000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	603092000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	130147000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	105130000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	502863000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	433413000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	478866000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	18521000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1722000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	451934000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	480588000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	18521000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1722000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1722000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	200000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	297887000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3254000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	66558000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	109742000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44281000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12509000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-73209000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13630000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-12056000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-73209000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13630000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-64230000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-42541000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-763000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-62747000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-35522000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5630000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-300128000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-9830000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8750000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-11327000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-12858000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-42765000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-19719000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-29523000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-12992000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-1962000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-64196000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-309938000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51849000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74273000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	3750000	shares
CY2015	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	165328000	USD
CY2016	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	169781000	USD
CY2017	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	163273000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	549365000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	262621000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	25716000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	7739000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1829000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2559000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3688000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5010000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	4891000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1990000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2116000	USD
CY2015	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	22864000	USD
CY2016	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	22025000	USD
CY2017	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	27725000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	763000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21769000	USD
CY2015	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	12056000	USD
CY2016	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	9870000	USD
CY2017	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	8680000	USD
CY2015	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2630000	USD
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	980000	USD
CY2017	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	236770000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5000000	USD
CY2016Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4950000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26973000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	42444000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	67516000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18507000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18620000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	83267000	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20777000	USD
CY2015	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	59691000	USD
CY2016	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	294446000	USD
CY2015	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	203663000	USD
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	104300000	USD
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	563000	USD
CY2015	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit		USD
CY2017	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	23060000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4177000	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	108364000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	115271000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32678000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	26608000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	23697000	USD
CY2017Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	0	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	109086000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	85522000	USD
CY2015	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	193663000	USD
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	64000000	USD
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	4398200	shares
CY2017	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	5106	shares
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1073000	USD
CY2017	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1072000	USD
CY2015	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	12550000	USD
CY2017	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	55863000	USD
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	395000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-645315000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-709511000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	4513000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	1801000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	2360000	USD
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2497766	shares
CY2015	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	6581000	USD
CY2015	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	9938000	USD
CY2017	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	9937000	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	83267000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20777000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	21000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	216589000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-81515000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-33621000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-84752000	USD
CY2015	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3690000	USD
CY2016	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	692000	USD
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	701000	USD
CY2015	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	6120000	USD
CY2016	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	8392000	USD
CY2017	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	9376000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5106	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	16000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1096000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1067000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1021000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1014000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	29000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	46000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	7000	USD
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68710000	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	93740000	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	123791000	shares
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period financial statement amounts have been reclassified to conform to current period presentation.</font></div></div>
CY2017	us-gaap	Revenue Recognition Rebates RevenueRecognitionRebates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rebates</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturers’ rebates are generally volume-based incentives that are earned and recorded upon purchase of the inventory. Rebates are recorded to cost of goods sold.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-18-003541-index-headers.html	Edgar Link	pending
0001628280-18-003541-index.html	Edgar Link	pending
0001628280-18-003541.txt	Edgar Link	pending
0001628280-18-003541-xbrl.zip	Edgar Link	pending
bios-20171231.xml	Edgar Link	completed
bios-20171231.xsd	Edgar Link	pending
bios-20171231x10k.htm	Edgar Link	pending
bios-20171231_cal.xml	Edgar Link	unprocessable
bios-20171231_def.xml	Edgar Link	unprocessable
bios-20171231_lab.xml	Edgar Link	unprocessable
bios-20171231_pre.xml	Edgar Link	unprocessable
bios-ex211xx20171231x10k.htm	Edgar Link	pending
bios-ex231xx20171231x10k.htm	Edgar Link	pending
bios-ex311xx20171231x10k.htm	Edgar Link	pending
bios-ex312xx20171231x10k.htm	Edgar Link	pending
bios-ex321xx20171231x10k.htm	Edgar Link	pending
bios-ex322xx201712x31x10k.htm	Edgar Link	pending
bioscriplogoa08.jpg	Edgar Link	pending
chart-fd82d1464522565587ca01.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2017 Q4 Form 10-K Financial Statement

#000162828018003541 Filed on March 26, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2017 Q4 Form 10-K Financial Statement

#000162828018003541 Filed on March 26, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch